Comparison of Two Bronchodilator Inhalers in Adolescents and Adults With Exercise-Induced Asthma

NCT00085774 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2021-11-24

No results posted yet for this study

Summary

This study was designed to examine the effectiveness of two bronchodilator inhalers in patients who have exercise-induced asthma.

Conditions

  • Exercise-induced Bronchospasm

Interventions

DRUG

albuterol aerosol by HFA MDI

albuterol HFA MDI 160 mcg

DRUG

albuterol aerosol by HFA BOI

albuterol HFA BOI 160 mcg

DRUG

placebo aerosol by HFA

placebo HFA

Sponsors & Collaborators

  • Teva Branded Pharmaceutical Products R&D, Inc.

    lead INDUSTRY

Principal Investigators

  • David S Pearlman, MD · Colorado Allergy and Asthma Centers, PC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
12 Years
Max Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2004-09-30
Completion
2004-09-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00085774 on ClinicalTrials.gov